This program is designed for individuals approaching the cannabis field through the primary lenses of health and wellness and herbal medicine. The training develops the research literacy necessary to acquire a deep understanding of cannabis safety, formulation, and quality assurance, which allows students to develop innovative strategies for commercializing safe and effective products. Clinicians gain the background needed to guide their patients in using cannabis as an adjunct therapy. The 15-credit program can be completed in 1 year and is delivered entirely online.
The program is designed for individuals who wish to promote evidence-informed, safe, and responsible use of high-quality cannabis-based products in combination with herbal medicine, especially those with a holistic approach and a focus on a health promotion model rather than a disease management model. The program is ideal for career starters and those seeking an initial career in the industry or looking to expand their job options.
The Post-Baccalaureate Certificate in Cannabis Science: Therapeutics, Product Design, and Quality Assurance is one of the few graduate programs in the U.S. dedicated solely to studying cannabis, and the only one that addresses cannabis through an herbal medicine and health and wellness lens. The coursework emphasizes developing research literacy and focuses on cannabis health effects, safety, formulation, and quality assurance. The program integrates cannabis legacy knowledge with the research from herbal medicine and cannabis fields necessary to develop innovative strategies for commercializing safe and effective cannabis products.
Unique to this program, students investigate ways to combine cannabis with other herbs to optimize health benefits and reduce risks. The certificate benefits from MUIH’s 20 years of experience offering graduate-level herbal medicine programs. Our herbal program faculty are specifically qualified to discuss cannabis within the framework of herbal medicine principles and practices, something quite distinct from a conventional medical or pharmaceutical perspective.
This is a non-experiential program. There are no internships, laboratories, field work, or hands on work with cannabis as part of this curriculum and program.
The Post-Baccalaureate Certificate in Cannabis Science is a graduate program, which differs from training programs offered in the field. Students gain skills that employers seek and which are not typically provided by non-credit training programs. These include critical thinking, problem solving, and research literacy skills. Click here for a description of the added value of a graduate program.
|Trimester of Entry:||Fall, Spring|
|Application Priority Deadline:||Application deadline by Trimester|
|Program Specific Requirements:||Complete Essay Questions in application:
The program consists of 15 credits of the following required courses:
Upon completion of the program graduates will be able to:
This program is offered in the online format. Click here to view MUIH’s definition of the online program format.
For trimester start and end dates, see the Academic Calendar.
The schedule of courses for this program is shown below:
|Trimester||Course Code||Cost per Credit||# of Credits||University Fee||Tuition Cost*|
*Prices subject to change. Tuition costs are for illustrative purposes only.
|Non-Refundable Tuition Deposit||$150|
|University Fee (per trimester)||$275
All students, including students taking a voluntary break in enrollment. Click here to learn more about the fee.
|Late Registration Fee
After registration deadline and before start of the schedule adjustment period for current students
During the schedule adjustment period for current students
The cannabis industry consists of three fields – 1) medical marijuana, 2) recreational marijuana, and 3) hemp-based, CBD-dominant cannabis. Each has experienced, and is projected to have, continued significant growth. The increase in use and sales of cannabis nationally is driving significant job growth in the field.
Legalization and Use
As of August 2022, medical cannabis is legal in 38 states, recreational cannabis is legal in 19 states, and hemp is federally legal in all 50 states. According to Gallup’s annual Consumption Habits poll, conducted on July 6, 2021, over 49% of U.S. adults have tried cannabis (1).
Medical and Recreational Cannabis Industry Sales Growth
New Frontier Data reports that overall sales within the legalized U.S. cannabis industry, including recreational and medical marijuana, reached $25 billion throughout 2021 (2). New Frontier projects annual U.S. legal cannabis sales to exceed $57 billion by 2030 in current legal states, and if the 18 additional state markets poised to legalize activate, this figure would top $72 billion (3). Globally, BDS Analytics projects sales of recreational cannabis at $83 billion and medical cannabis at $19 billion by 2027 (4). For example, on a state level, Maryland’s medical cannabis market for 2021 reached $600 million in sales, while sales in 2022 thru August were ~$360 million (5). In November 2022, Maryland voters elected to legalize recreational cannabis. Globally, Fortune Business Insights reports the cannabis market (including medical, recreational, and hemp-based) was $10.6 billion in 2018 and projects it to reach $97.3 billion by the end of 2026, a 33% annual growth from 2019 to 2026 (6).
CBD Industry Growth
Significant consumer interest exists in hemp-based and CBD-containing cannabis supplements. Hemp-derived CBD is now available in general retail channels outside licensed cannabis dispensaries, including online, drug stores, natural products, beauty, convenience, grocery, and pet stores. Hemp-based cannabis sales of CBD-based supplements grew 332% from 2018 to 2019, with over $52 million in 2019 sales, making hemp-based cannabis supplements the top selling herbal supplement in the U.S. market (7). Current herbal supplement manufacturers are increasingly embracing CBD based cannabis products. The percent of natural product manufacturers selling such products doubled in the first six months of 2019, with 75% of the industry planning on launching new CBD-based products over the next two years (8).
Cannabis Industry Job Growth
The 2022 MJBiz Factbook estimates the number of full-time workers in the U.S. cannabis industry to be upwards of 520,000 in 2022. By 2025, jobs are expected to approach 675,000 (2). The number of jobs is expected to grow even faster once federal law is changed.
The career opportunities vary based on the segment of the market (medical vs. recreational vs. hemp-based cannabis). However, all three segments demand similar knowledge and skill sets that are basic to the world of herbal supplements. Nationally based cannabis-specific hiring firm Vangst provides a benchmarking salary guide for working in the cannabis industry and the requirements for employment in each state (9).
Careers for which graduates of the Post-Baccalaureate Certificate in Cannabis Science may qualify:
Take a look at what our Post-Baccalaureate Certificate in Cannabis Science program offers and how MUIH is the choice for you!
There are no upcoming events at this time.
James Snow D.C.N
Michael (Bhodi) Tims, Ph.D.
Program Director, Herbal Product Design and Manufacture
Program Director, Cannabis Science: Therapeutics, Product Design and Quality Assurance
Rachel Voss, M.P.A.
Devyn Cain, M.S.